The Clozapine Handbook

Stahl's Handbooks

; Stephen M. Stahl

A practical Handbook that provides clinically-focussed approaches and guidelines on the effective management of clozapine treated patients. Les mer
Vår pris
540,-

(Paperback) Fri frakt!
Leveringstid: Sendes innen 7 virkedager

Paperback
Legg i
Paperback
Legg i
Vår pris: 540,-

(Paperback) Fri frakt!
Leveringstid: Sendes innen 7 virkedager

Om boka

A practical Handbook that provides clinically-focussed approaches and guidelines on the effective management of clozapine treated patients.

Fakta

Innholdsfortegnelse

Preface; 1. Initiating Clozapine; 2. Understanding hematologic monitoring and benign ethnic neutropenia; 3. Binding profile, metabolism, kinetics, drug interactions and use of plasma levels; 4. Managing constipation; 5. Managing sialorrhea; 6. Managing sedation, orthostasis and tachycardia; 7. Managing metabolic adverse effects; 8. Managing seizure risk and stuttering; 9. Fever, myocarditis, interstitial nephritis, DRESS, serositis and cardiomyopathy; 10. Eosinophilia, leukocytosis, thrombocytopenia, thrombocytosis, anemia, hepatic function abnormalities; 11. Managing enuresis and incontinence, priapism, venous thromboembolism, neuroleptic malignant syndrome, tardive dyskinesia and obsessive compulsive disorder; 12. The efficacy story: treatment resistant schizophrenia, psychogenic polydipsia, treatment intolerant schizophrenia, suicidality, violence, mania and Parkinson's disease psychosis; 13. Addressing clozapine positive symptom nonresponse in schizophrenia spectrum patients; 14. Discontinuing clozapine and management of cholinergic rebound; 15. Special topics: child and adolescent patients, elderly patients, patients with intellectual disability, pregnancy and risk for major congenital malformation, lactation, overdose, postmortem redistribution; Index.

Om forfatteren

Jonathan M. Meyer is currently a Clinical Professor of Psychiatry at the University of California, San Diego and a Psychopharmacology Consultant to the California Department of State Hospitals. Dr Meyer is an internationally recognised speaker on psychopharmacology and the treatment of severe mental illness, and is Distinguished Fellow of the American Psychiatric Association. Stephen M. Stahl is currently a Professor at the University of California, San Diego and serves as Honorary Fellow in the psychiatry department at the University of Cambridge. He is also the Chairman of the Neuroscience Education Institute (NEI) and Arbor Scientia Group. Dr Stahl serves as the Director of Psychopharmacology Services at the California Department of State Hospitals as well as the Editor-in Chief of CNS Spectrums.